诊断检测中的不规则分析误差:一个新概念
该文提出「不规则(个体)分析误差」新术语,指单个样本检测结果的不准确度超出常规批级质控所解释的测量不确定度。其偏差可定义为过程测量不确定度与方法偏倚的线性组合,源于样本基质个体效应或单样本处理错误,并列出可复现与偶发两类原因。
要点
- 常规批级质控无法覆盖单个样本的分析误差。
- 不规则分析误差指结果偏差超出过程质控可解释的测量不确定度。
- 原因包括抗试剂抗体等可复现误差及气泡致加样错误等偶发误差。
核心结论
- 单个样本的分析不准确度若超出常规过程质控的测量不确定度,应称为该样本的不规则分析误差。
研究设计与样本
- 本文为概念性文章,提出新术语并基于定义列出临床化学中已识别的风险原因清单。
主要发现
- 常规内外质控仅作用于批水平,任何单个样本并未处于个体质控之下。
- 不规则分析误差的偏差可定义为过程测量不确定度与参考测量系统方法偏倚的线性组合。
- 该类误差源于样本个体组成(基质)的不规则效应或分析过程中单样本处理错误。
关键数值与推荐
- 不规则分析误差定义为:与参考测量程序结果的偏差高到无法由常规检测在过程质控可接受限内运行的测量不确定度解释。
临床怎么用
- 对可溯源至参考测量系统的检测项目,应关注单个样本结果偏差是否超出过程质控可解释范围。
局限性
- 目前参考测量程序的可用性仍非常有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In laboratory medicine, routine periodic analyses for internal and external quality control measurements interpreted by statistical methods are mandatory for batch clearance. Data analysis of these process-oriented measurements allows for insight into random analytical variation and systematic calibration bias over time. However, in such a setting, any individual sample is not under individual quality control. The quality control measurements act only at the batch level. Quantitative or qualitative data derived for many effects and interferences associated with an individual diagnostic sample can compromise any analyte. It is obvious that a process for a quality-control-sample-based approach of quality assurance is not sensitive to such errors. CONTENT: To address the potential causes and nature of such analytical interference in individual samples more systematically, we suggest the introduction of a new term called the irregular (individual) analytical error. Practically, this term can be applied in any analytical assay that is traceable to a reference measurement system. For an individual sample an irregular analytical error is defined as an inaccuracy (which is the deviation from a reference measurement procedure result) of a test result that is so high it cannot be explained by measurement uncertainty of the utilized routine assay operating within the accepted limitations of the associated process quality control measurements. SUMMARY: The deviation can be defined as the linear combination of the process measurement uncertainty and the method bias for the reference measurement system. Such errors should be coined irregular analytical errors of the individual sample. The measurement result is compromised either by an irregular effect associated with the individual composition (matrix) of the sample or an individual single sample associated processing error in the analytical process. OUTLOOK: Currently, the availability of reference measurement procedures is still highly limited, but LC-isotope-dilution mass spectrometry methods are increasingly used for pre-market validation of routine diagnostic assays (these tests also involve substantial sets of clinical validation samples). Based on this definition/terminology, we list recognized causes of irregular analytical error as a risk catalog for clinical chemistry in this article. These issues include reproducible individual analytical errors (e.g. caused by anti-reagent antibodies) and non-reproducible, sporadic errors (e.g. errors due to incorrect pipetting volume due to air bubbles in a sample), which can both lead to inaccurate results and risks for patients.
引用
- Vogeser M, Seger C. Irregular analytical errors in diagnostic testing - a novel concept. Clin Chem Lab Med. 2018. PMID: 28902615. doi:10.1515/cclm-2017-0454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。